Frequency of adverse events Up to 15 years [clinicaltrials_resource:d27a1e83ff874fb8cfcc21e8d5b49953]

Frequency of adverse events Up to 15 years [clinicaltrials_resource:d27a1e83ff874fb8cfcc21e8d5b49953]

Evaluated by the frequency and relationship of dose-limiting toxicities, if any, experienced by patients during dose escalation.
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:d27a1e83ff874fb8cfcc21e8d5b49953
Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx [clinicaltrials:NCT00064103]
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Frequency of adverse events Up to 15 years [clinicaltrials_resource:d27a1e83ff874fb8cfcc21e8d5b49953]

Evaluated by the frequency and relationship of dose-limiting toxicities, if any, experienced by patients during dose escalation.
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:d27a1e83ff874fb8cfcc21e8d5b49953
Bio2RDF identifier
d27a1e83ff874fb8cfcc21e8d5b49953
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d27a1e83ff874fb8cfcc21e8d5b49953
measure [clinicaltrials_vocabulary:measure]
Frequency of adverse events
time frame [clinicaltrials_vocabulary:time-frame]
description
Evaluated by the frequency and ...... tients during dose escalation.
identifier
clinicaltrials_resource:d27a1e83ff874fb8cfcc21e8d5b49953
title
Frequency of adverse events Up to 15 years
@en
inDataset
type
label
Frequency of adverse events Up ...... a1e83ff874fb8cfcc21e8d5b49953]
@en